Galaxy Medicare Ltd vs Invicta Diagnostic Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 26, 2026

Key Highlights

The Latest Trading Price of Galaxy Medicare Ltd is ₹ 17.15 as of 26 Oct 15:30 . The P/E Ratio of Galaxy Medicare Ltd is 0 as of March 2024 .The P/E Ratio of Invicta Diagnostic Ltd is 0 as of March 2024 . The Market Cap of Galaxy Medicare Ltd is ₹ 0 crore as of March 2024 .The Market Cap of Invicta Diagnostic Ltd is ₹ 0 crore as of March 2024 . The Dividend Payout of Galaxy Medicare Ltd changed from 26.39 % on March 2025 to 0 % on March 2023 . This represents a CAGR of -100.00% over 5 yearsThe Dividend Payout of Invicta Diagnostic Ltd changed from 0 % on March 2024 to 0 % on March 2023 . This represents a CAGR of 0.0% over 6 years .

About Galaxy Medicare Ltd

Galaxy Medicare Limited was originally established on July 23, 1992 as a Limited Company in the Mancheshwar Industrial area of Bhubaneswar, Orissa.
The Company commenced its operations in 1992 when the founder, Mr. Dillip Kumar Das, acquired a closed business unit, M/s Cure Aids Private Limited from Odisha Industrial Infrastructure Development Corporation (IDCO) and Odisha State Financial Corporation under the investment promotion, facilitation and aftercare strategy of Industrial Promotion and Investment Corporation of Odisha (IPICOL) and revived the business unit to start manufacturing of Medical Devices such as Plaster of Paris Bandage (POP Bandage), Medical Tapes and Bandages, Other surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, medical disposable, adhesive bandages, absorbent gauze, etc.

About Invicta Diagnostic Ltd

Invicta Diagnostic Limited was incorporated as Limited Liability Partnership under the name 'Invicta Diagnostic LLP' vide Certificate of Incorporation dated January 22, 2021 issued by Assistant Registrar of Companies, Central Registration Centre.
Further, Invicta Diagnostic LLP converted into a Private Limited Company as 'Invicta Diagnostic Private Limited' dated December 01, 2023.
Subsequently, Company converted from a Private Limited to a Public Limited Company, and the name was changed to 'Invicta Diagnostic Limited' and a fresh Certificate of Incorporation dated July 02, 2024 was issued by the Central Processing Centre. Invicta Diagnostic Limited is an innovative diagnostic chain in Mumbai Metropolitan Region (MMR) offering comprehensive radiology and pathology solutions.
It offer a one-stop solution for pathology and radiology testing services such as imaging (including radiology) and pathology/clinical laboratory to customers through a network, consisting of 8 diagnostic centres and 1 centralised laboratory across Mumbai Metropolitan Region in Maharashtra.

FAQs for the comparison of Galaxy Medicare Ltd and Invicta Diagnostic Ltd

Which company has a larger market capitalization, Galaxy Medicare Ltd or Invicta Diagnostic Ltd?

Market cap of Galaxy Medicare Ltd is 26 Cr while Market cap of Invicta Diagnostic Ltd is 79 Cr

What are the key factors driving the stock performance of Galaxy Medicare Ltd and Invicta Diagnostic Ltd?

The stock performance of Galaxy Medicare Ltd and Invicta Diagnostic Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Galaxy Medicare Ltd and Invicta Diagnostic Ltd?

As of October 26, 2026, the Galaxy Medicare Ltd stock price is INR ₹17.15. On the other hand, Invicta Diagnostic Ltd stock price is INR ₹63.0.

How do dividend payouts of Galaxy Medicare Ltd and Invicta Diagnostic Ltd compare?

To compare the dividend payouts of Galaxy Medicare Ltd and Invicta Diagnostic Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.